Diffusion Pharmaceuticals

About:

Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.

Website: http://www.diffusionpharma.com

Twitter/X: DiffusionPharma

Top Investors: Third Security, Jaffray Woodriff, Office of Naval Research

Description:

Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Diffusion’s lead product candidate, TSC, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. In addition to TSC, Diffusion’s product candidate DFN-529, a novel PI3K/Akt/mTOR pathway inhibitor, is in early-stage development.